Neurally mediated syncope

Pathophysiology and implications for treatment

Rose Marie Robertson, Eduardo Medina, Nihal Shah, Raffaello Furlan, Rogelio Mosqueda-Garcia

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Neurally mediated syncope may occur in patients whose hemodynamic picture does not fit the characteristics of orthostatic intolerance as described elsewhere in this issue. Nonetheless, patients who suffer from neurocardiogenic or vasovagal syncope may be seriously incapacitated by their episodes of syncope or presyncope. Although it has been assumed that vagal activation as a result of stimulation of ventricular mechanoreceptors is essential to the production of these episodes, several critical observations are presented that suggest that other mechanisms may also be operative in some patient subsets. In addition, evidence is presented that the sympathetic responses of many of these patients may be reduced rather than increased and that abnormal baroreflex responsiveness may also play an causative role. These findings suggest new avenues for therapy in this field in which carefully controlled, randomized, double-blind trials are scarce.

Original languageEnglish
Pages (from-to)102-109
Number of pages8
JournalAmerican Journal of the Medical Sciences
Volume317
Issue number2
DOIs
Publication statusPublished - Feb 1999

Fingerprint

Syncope
Vasovagal Syncope
Orthostatic Intolerance
Mechanoreceptors
Baroreflex
Therapeutics
Hemodynamics

Keywords

  • Baroreflex
  • Neurocardiogenic
  • Parasympathetic
  • Sympathetic
  • Syncope

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Neurally mediated syncope : Pathophysiology and implications for treatment. / Robertson, Rose Marie; Medina, Eduardo; Shah, Nihal; Furlan, Raffaello; Mosqueda-Garcia, Rogelio.

In: American Journal of the Medical Sciences, Vol. 317, No. 2, 02.1999, p. 102-109.

Research output: Contribution to journalArticle

Robertson, Rose Marie ; Medina, Eduardo ; Shah, Nihal ; Furlan, Raffaello ; Mosqueda-Garcia, Rogelio. / Neurally mediated syncope : Pathophysiology and implications for treatment. In: American Journal of the Medical Sciences. 1999 ; Vol. 317, No. 2. pp. 102-109.
@article{4091ef42a2e34b1198c19e5844c0d460,
title = "Neurally mediated syncope: Pathophysiology and implications for treatment",
abstract = "Neurally mediated syncope may occur in patients whose hemodynamic picture does not fit the characteristics of orthostatic intolerance as described elsewhere in this issue. Nonetheless, patients who suffer from neurocardiogenic or vasovagal syncope may be seriously incapacitated by their episodes of syncope or presyncope. Although it has been assumed that vagal activation as a result of stimulation of ventricular mechanoreceptors is essential to the production of these episodes, several critical observations are presented that suggest that other mechanisms may also be operative in some patient subsets. In addition, evidence is presented that the sympathetic responses of many of these patients may be reduced rather than increased and that abnormal baroreflex responsiveness may also play an causative role. These findings suggest new avenues for therapy in this field in which carefully controlled, randomized, double-blind trials are scarce.",
keywords = "Baroreflex, Neurocardiogenic, Parasympathetic, Sympathetic, Syncope",
author = "Robertson, {Rose Marie} and Eduardo Medina and Nihal Shah and Raffaello Furlan and Rogelio Mosqueda-Garcia",
year = "1999",
month = "2",
doi = "10.1097/00000441-199902000-00004",
language = "English",
volume = "317",
pages = "102--109",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Neurally mediated syncope

T2 - Pathophysiology and implications for treatment

AU - Robertson, Rose Marie

AU - Medina, Eduardo

AU - Shah, Nihal

AU - Furlan, Raffaello

AU - Mosqueda-Garcia, Rogelio

PY - 1999/2

Y1 - 1999/2

N2 - Neurally mediated syncope may occur in patients whose hemodynamic picture does not fit the characteristics of orthostatic intolerance as described elsewhere in this issue. Nonetheless, patients who suffer from neurocardiogenic or vasovagal syncope may be seriously incapacitated by their episodes of syncope or presyncope. Although it has been assumed that vagal activation as a result of stimulation of ventricular mechanoreceptors is essential to the production of these episodes, several critical observations are presented that suggest that other mechanisms may also be operative in some patient subsets. In addition, evidence is presented that the sympathetic responses of many of these patients may be reduced rather than increased and that abnormal baroreflex responsiveness may also play an causative role. These findings suggest new avenues for therapy in this field in which carefully controlled, randomized, double-blind trials are scarce.

AB - Neurally mediated syncope may occur in patients whose hemodynamic picture does not fit the characteristics of orthostatic intolerance as described elsewhere in this issue. Nonetheless, patients who suffer from neurocardiogenic or vasovagal syncope may be seriously incapacitated by their episodes of syncope or presyncope. Although it has been assumed that vagal activation as a result of stimulation of ventricular mechanoreceptors is essential to the production of these episodes, several critical observations are presented that suggest that other mechanisms may also be operative in some patient subsets. In addition, evidence is presented that the sympathetic responses of many of these patients may be reduced rather than increased and that abnormal baroreflex responsiveness may also play an causative role. These findings suggest new avenues for therapy in this field in which carefully controlled, randomized, double-blind trials are scarce.

KW - Baroreflex

KW - Neurocardiogenic

KW - Parasympathetic

KW - Sympathetic

KW - Syncope

UR - http://www.scopus.com/inward/record.url?scp=0032737258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032737258&partnerID=8YFLogxK

U2 - 10.1097/00000441-199902000-00004

DO - 10.1097/00000441-199902000-00004

M3 - Article

VL - 317

SP - 102

EP - 109

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 2

ER -